Cypin Production is launching its first eSummit on April 11 on Market Access, Pricing and Reimbursement Strategies (Focus: Brazil, Russia, China). Join us at this fast pace 90-minute program and learn about how the massive healthcare reforms in the BRC countries will affect your market expansion plan. The country specific presentations followed by Q&A and discussions will keep you abreast of the latest market conditions and prepare for unforeseen challenges and competitions. This 90-minute program includes:
Health Reform in Brazil and What it Means to You?
- Addressing concerns of market access: price setting and slow product approvals
- Understanding the role of the National Health Surveillance Agency (ANVISA) and how it will affect future approval process
- Managing generic drugs and IP challenges
- Overcoming reimbursement and regulatory challenge
Why 2012 Presents Huge Opportunities in Russia?
- What are the changes to the reimbursement categories?
- Understanding government legislation and what it means, particularly "On Drug Circulation in the Russian Federation"
- Reviewing the "Pharma2020" program and its consequences
- Surviving the pending pricing control in Russia
What Does the Future Hold for Market Access in China?
- Evaluating key reforms on pricing controls and reimbursement and how that will affect your company
- Getting an update on the progress of the national healthcare reform program
- Profiting from market affordability schemes and pricing scheme
Presenters:
Monica Martin de Bustamante,
Principal, Global Market Access,
Insight Strategy Advisors
Maria Avxentyeva,
Deputy Director, Research Institute of Clinico-economic Expertise and Pharmacoeconomics,
Russian State Medical University
Chia Wen Lee Grossman,
Director, Emerging Market, Market Access,
Biogen Idec